How we’re taking
the next big step
From the Nano to the Macro, we’re developing next generation polymer technology. Our tech will power the manufacture of innovative medical products for years to come.
Nanoparticles & Microparticles
Gels & Films
3D Printed Implants
tunable parameters, tunable results
Our polymers outperform old drug delivery systems.
|Variables||Biomedical Polymer Systems|
|Polymer (PCL, PLA)||Copolymers (PLGA)||Pendant Polymers|
|Degree of crosslinking|
Through technology, we access major underserved market segments.
Global Injectable Drug Delivery = $404B in 2017, $1200B by 2026*
Pendant Bio’s technology accesses two major market segments:
Total Injectables Market
Surface Coatings Market
*Research and Markets, 2018; 1BCC Research, 2018; 2Statistics MRC and Wiseguys Reports, 2018
Intellectual property fuels growth.
PCT Filed: 1
Flexibility drives differentiation.
Pendant Bio is better at drug delivery because our affordable polymer platform is more versatile than old systems, and can more predictably solve today’s most difficult drug delivery challenges regardless of the active pharmaceutical ingredient.
Pendant Bio is better at coatings because we’ve combined a surface modification system with a drug delivery platform, which provides more flexibility to design the differentiated products required for success in today’s medical device arena.